The Access to Insight Grants Core Faculty is pleased to announce Access to Insight – the Novo Nordisk Haemostasis Grants Initiative, which offers exciting funding opportunities specially tailored to the needs of talented haemostasis physicians and researchers.
Novo Nordisk, a healthcare company with a leading position in haemostasis management, is strongly committed to supporting haemostasis research and education.
The initiative is steered by the Access to Insight Grants Core Faculty, a group of distinguished haemostasis experts chaired by Nigel Key, MB ChB, FRCP, from the University of North Carolina School of Medicine and the Harold R. Roberts Comprehensive Haemophilia Diagnostic and Treatment Centre in Chapel Hill, NC, USA.
Overview of Access to Insight funding opportunities
Basic Research Grant
- up to € 70,000
- 12–18 month period
- Focus: Basic science or translational
research relevant to the under-
standing of the pathophysiology
and treatment of haemostatic
disorders
Clinical Research Grant
- up to € 70,000
- 12 month period
- Focus: Innovative haemostatic
research on patient outcomes,
quality of life, and social impacts
Services
Newsletter
The Haemophilia Academy is an independently run training programme led by a distinguished faculty of haemophilia experts.
More
